Exovesicular-Shh Confers Imatinib Resistance by Upregulating Bcl2 Expression in Chronic Myeloid Leukemia with Variant Chromosomes

0
7
The authors identified the molecular mechanism of Sonic hedgehog (Shh)-mediated mutation-independent Imatinib resistance that is most relevant for treating chronic myeloid leukemia-variants and non-compliant patients.
[Cell Death & Disease]
Anusha, Dalal, H., Subramanian, S., P, S. V., Gowda, D. A., H, K., Damodar, S., & Vyas, N. (2021). Exovesicular-Shh confers Imatinib resistance by upregulating Bcl2 expression in chronic myeloid leukemia with variant chromosomes. Cell Death & Disease, 12(3), 1–17. https://doi.org/10.1038/s41419-021-03542-w Cite
Abstract